Jonathan Violin - Chief Executive Officer, Viridian Therapeutics, Inc\de

As of May 4, 2022

Net worth is estimated to be at least $3.71M
Owns at least 510,905 units of Viridian Therapeutics, Inc\de stock
Sold an estimated value of $2.06M in the last year at Viridian Therapeutics, Inc\de

Largest sale of shares was 30,000 units , worth over $572.82K on February 3, 2022
In total has made about 6 transactions over a year
Usually trades in December, April, January, May, March and February, with the busiest year in 2022

	Ticker	Type	Value	Price per Share	Shares	Filing Date
No matching records found

Mailing address is 955 Chesterbrook Boulevard Suite 200 Chesterbrook PA 19087 PA

Name	Year	Salary	Bonus	Option Awards	Other Compensation	Total
William S. Marshall, Ph.D.	2020	$424,832	$	$585,128	$1,176,859	$2,186,819
William S. Marshall, Ph.D.	2019	$521,000	$	$551,302	$3,640	$1,075,942
Lee Rauch	2020	$256,436	$270,500	$1,139,677	$3,798	$1,670,411
Jason A. Leverone	2020	$365,650	$	$112,715	$4,655	$483,020
Jason A. Leverone	2019	$355,000	$	$178,223	$4,584	$537,807
Diana Escolar, M.D.	2020	$417,473	$277,780	$164,492	$5,873	$865,618
Diana Escolar, M.D.	2019	$372,600	$111,780	$59,408	$6,217	$550,005
No matching records found

The most recent transaction was 30,000 units sold on May 4, 2022 by Jonathan Violin worth over $391.2K
In the last year, insiders at Viridian Therapeutics, Inc\de sold an estimated value of $2.06M and bought an estimated value of $12.2M
The most active traders are Jonathan Violin, Chief Executive Officer, Kristian Humer, CFO and CBO, and Arlene Morris, Director
Insider trading is most common in February, with the busiest year in 2021

	Insider Names	Type	Value	Price per Share	Shares	Filing Date
No matching records found